头孢哌酮舒巴坦并用盐酸氨溴索治疗慢阻肺临床效果观察

Clinical Observation of Cefoperazone and Sulbactam Combined with Ambroxol Hydrochloride in the Treatment of Chronic Obstructive Pulmonary Disease

目的:分析研究头孢哌酮舒巴坦并用盐酸氨溴索治疗慢阻肺临床效果。方法:选择本院接收的慢阻肺患者作为研究对象,符合研究内容者共计40例,对其临床资料展开分析,将其分为对照组20例(常规治疗)和观察组20例(头孢哌酮舒巴坦、盐酸氨溴索结合治疗),对比治疗效果、临床症状消失时间和住院时间。结果:分析治疗效果,和对照组(70.00%)相比,观察组(95.00%)更高,P<0.05。观察组临床症状消失时间(6.08±0.06)和住院时间(7.21±1.09)较对照组短,P<0.05。结论:实施头孢哌酮舒巴坦、盐酸氨溴索结合治疗方法,对慢阻肺患者具有缩短临床症状时间和住院时间的效果,很大程度上提高了治疗有效率,在临床中值得应用和推广。

Objective:To analyze the clinical effects of cefoperazone and sulbactam combined with ambroxol hydrochloride in the treatment of chronic obstructive pulmonary disease.Method:Select the COPD patients accepted by this hospital as the research object,a total of 40 cases meet the research content,analyze their clinical data,and divide them into the control group 20 cases(conventional treatment)and observation Group of 20 patients(cefoperazone and sulbactam,ambroxol hydrochloride combined treatment),compared the treatment effect,clinical symptoms disappearance time and hospital stay.Results:Analysis of the treatment effect,compared with the control group(70.00%),the observation group(95.00%)was higher,P<0.05.The clinical symptom disappearance time(6.08±0.06)and hospitalization time(7.21±1.09)of the observation group were shorter than those of the control group,P<0.05.Conclusion:The combined treatment of cefoperazone and sulbactam and ambroxol hydrochloride has the effect of shortening the time of clinical symptoms and hospitalization for patients with chronic obstructive pulmonary disease,greatly improving the effective rate of treatment,and it is worthy of application in clinical practice.Promotion.